EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All ResourcesChallenges of the Cell, Gene, CAR-T and Personalized Medicine Supply Chains
Topics: Cold Chain, Conference, Supply Chain
Video
Members
GCSG Presentation Tips from Steve Jacobs
Topics: Communication, Personal Development
Conference Training
Members
